A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

A proof of concept study suggests an FT-IR microspectroscopy blood test can detect a single circulating tumour cell in a lung cancer patient, supporting future real time monitoring.

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

A team of researchers from three different institutions from the UK have come up with a technique to detect and monitor the ...

ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ -- Four clinical trials to be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition illustrate how advancements in ...

Those harrowing words came over the phone to Karen Burns White last year while she was en route with friends to a jazz festival in Maryland. She had taken a blood test intended to detect multiple ...